Our Pricing

Cheap Wegovy Online: UK's Lowest Price From £79.00

Finding cheap Wegovy online UK options doesn't mean compromising on quality or safety. At Cured Pharmacy, genuine UK-licensed Wegovy (semaglutide) pens start from £79.00, with transparent upfront pricing, free clinical consultation by UK prescribers, and 100% discreet delivery to your door.

Why Wegovy Costs Less at Cured Pharmacy

Cured Pharmacy operates as a fully digital UK-registered pharmacy (GPhC 9012511), eliminating the overhead costs of high-street premises. This operational efficiency allows us to offer cheap Wegovy online UK pricing whilst maintaining the highest clinical and regulatory standards under superintendent pharmacist Tarun Kumar (GPhC 2233073).

Unlike traditional pharmacies, we display exact pricing before your consultation begins. Wegovy starts from £79.00 per pen, with no hidden fees or surprise charges after your clinical assessment. All prices include UK prescriber review, medication dispensing, and discreet packaging.

Every Wegovy pen is sourced directly from UK-licensed wholesalers and stored in our GPhC-regulated facility. You receive the identical product dispensed by any UK pharmacy, but at lower prices guaranteed across the UK market.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone your gut releases after eating [1]. This medication works through three complementary mechanisms: slowing gastric emptying so you feel fuller for longer, reducing appetite signals in the brain, and improving blood sugar regulation.

In the landmark STEP 1 clinical trial, participants using Wegovy alongside lifestyle modifications achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. Importantly, 83.5% of participants on semaglutide lost at least 5% of their baseline weight — a threshold associated with significant metabolic health improvements [2].

The medication is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm. Your UK prescriber will determine the appropriate starting dose and gradual escalation schedule based on your individual tolerance and response.

Who Can Use Wegovy in the UK

Wegovy is licensed by the MHRA for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Your online clinical assessment will verify eligibility before any prescription is issued.

All prescription medications at Cured Pharmacy require assessment by a UK-registered prescriber. The consultation takes under 3 minutes and covers your medical history, current medications, and treatment goals to ensure Wegovy is clinically appropriate and safe for you.

Wegovy vs Other Weight Loss Injections

The UK market now offers several GLP-1 receptor agonist injections for weight management, each with distinct characteristics. Wegovy (semaglutide) was the first weekly GLP-1 injection specifically licensed for chronic weight management in the UK, backed by extensive STEP trial data demonstrating sustained weight loss over 68 weeks [1][2].

Saxenda contains liraglutide, an earlier-generation GLP-1 agonist requiring daily injections rather than weekly administration. Whilst effective, the daily injection schedule and slightly lower average weight loss outcomes make it less convenient for many patients seeking long-term treatment adherence.

Your UK prescriber will discuss which treatment aligns best with your medical history, lifestyle preferences, and weight management goals. Factors including injection frequency, side effect profiles, existing medical conditions, and treatment costs all inform this clinical decision.

Switching Between Weight Loss Medications

Some patients begin with one GLP-1 medication and later switch to another based on tolerance, efficacy, or availability. Any medication change requires prescriber approval and often involves a washout period or dose adjustment to minimise side effects.

If you're currently using another weight loss injection and considering Wegovy, mention this during your online consultation. Your prescriber will review your treatment history and determine the safest transition protocol.

Starting Your Wegovy Treatment at Cured Pharmacy

Begin by completing our free online consultation, which takes under 3 minutes. You'll answer questions about your weight history, current health conditions, medications, and previous weight loss attempts. A UK-registered prescriber reviews your responses, typically within hours.

If Wegovy is deemed clinically appropriate, your prescription is sent electronically to our dispensing team. We source your medication from UK-licensed suppliers, perform final clinical checks, and package it discreetly for next-day delivery to your chosen address.

Your first Wegovy pen will be the 0.25mg starter dose, as recommended by MHRA prescribing guidelines. The dose gradually increases every four weeks — 0.5mg, 1mg, 1.7mg, and finally the maintenance dose of 2.4mg — allowing your body to adjust and minimising gastrointestinal side effects [3].

Managing Wegovy Side Effects

The most commonly reported side effects are gastrointestinal: nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. In clinical trials, these symptoms were typically mild to moderate, most frequent during dose escalation, and diminished over time as the body adapted [1][2].

Practical strategies can reduce side effect severity. Eat smaller, more frequent meals rather than large portions. Avoid high-fat and heavily spiced foods, especially during the first weeks of each new dose. Stay well-hydrated, and consider taking the injection on the same day each week when you can rest if needed.

Rare but serious side effects include pancreatitis, gallbladder problems, and allergic reactions. Seek immediate medical attention if you experience severe persistent abdominal pain, yellowing of skin or eyes, difficulty breathing, or facial swelling. Your prescriber will discuss full risk information during your consultation.

When to Contact Your Prescriber

Contact our clinical team if side effects persist beyond the first few weeks, worsen with each dose increase, or significantly impact your daily activities. Dose adjustments or temporary treatment pauses may be appropriate in some cases.

Never increase your Wegovy dose faster than prescribed, even if you're tolerating it well. The gradual escalation protocol is designed to optimise both efficacy and safety based on extensive clinical trial data.

Maximising Weight Loss Results with Wegovy

Wegovy is licensed as an adjunct to a reduced-calorie diet and increased physical activity, not as monotherapy [3]. Clinical trial participants who achieved the greatest weight loss combined semaglutide with structured lifestyle interventions including dietary counselling and regular exercise.

Aim for a calorie deficit of 500-750 kcal per day through a combination of reduced intake and increased activity. Focus on nutrient-dense whole foods — lean proteins, vegetables, fruits, whole grains — which promote satiety and provide essential micronutrients during weight loss.

Regular physical activity enhances results and preserves lean muscle mass during weight reduction. The NHS recommends at least 150 minutes of moderate-intensity activity weekly, such as brisk walking, cycling, or swimming. Resistance training twice weekly helps maintain metabolic rate as you lose weight.

Track your progress through regular weigh-ins, body measurements, and how your clothes fit rather than daily scale fluctuations. Weight loss with Wegovy is gradual and sustained — expect consistent reductions over months rather than dramatic weekly drops. Most patients see meaningful results after 12-16 weeks at therapeutic doses.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., Rudofsky, G., Tadayon, S., Wadden, T. A., & Dicker, D. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.